Starling Oncology director Brad Hively reports sale of 298,853 common shares worth $1.95 million
STLN•Director sale reported in August
- Starling Oncology director Brad Hively sold 298,853 common shares on Aug. 21, 2026 at a weighted average of $6.51.
- His directly held stake fell to 411,976 shares following the transaction.
